Cortical pathology and cognitive impairment in multiple sclerosis

References

• Charcot JM. Lectures on Diseases of the Nervous System. New Sydenham Society, London, UK (1877).
   Google Scholar
• Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology41(5), 692–696 (1991).
   PubMed Web of Science ®Google Scholar
• Schultheis MT, Garay E, DeLuca J. The influence of cognitive impairment on driving performance in multiple sclerosis. Neurology56, 1089–1094 (2001).
   PubMed Web of Science ®Google Scholar
• Patti F. Cognitive impairment in multiple sclerosis. Mult. Scler.15(1), 2–8 (2009).
   PubMed Web of Science ®Google Scholar
• Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology41(5), 685–691 (1991).
   PubMed Web of Science ®Google Scholar
• Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J. Neurol. Sci.245(1–2), 41–46 (2006).
   PubMed Web of Science ®Google Scholar
• Nocentini U, Pasqualetti P, Bonavita S et al. Cognitive dysfunction in patients with relapsing–remitting multiple sclerosis. Mult. Scler.12(1), 77–87 (2006).
   PubMed Web of Science ®Google Scholar
• Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol.7(12), 1139–1151 (2008).
   PubMed Web of Science ®Google Scholar
• Winkelmann A, Engel C, Apel A, Zettl UK. Cognitive impairment in multiple sclerosis. J. Neurol.254(2), 35–42 (2007). Erratum in: J. Neurol.255(2), 309–310 (2008).
   Google Scholar
• Foong J, Rosewicz L, Chong WK, Thompson AJ, Miller DH, Ron MA. A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J. Neurol.247(2), 97–101 (2000).
   PubMed Web of Science ®Google Scholar
• Comi G, Filippi M, Martinelli V et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J. Neurol. Sci.132(2), 222–227 (1995).
   PubMed Web of Science ®Google Scholar
• Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH. Cognitive impairment and decline in different MS subtypes. J. Neurol. Sci.245, 187–194 (2006).
   PubMed Web of Science ®Google Scholar
• Potagas C, Giogkaraki E, Koutsis G et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J. Neurol. Sci.267, 100–106 (2008).
   PubMed Web of Science ®Google Scholar
• Callanan MM, Logsdail SJ, Ron MA, Warrington EK. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain112(Pt 2), 361–374 (1989).
   PubMed Web of Science ®Google Scholar
• Feinstein A, Youl B, Ron M. Acute optic neuritis. A cognitive and magnetic resonance imaging study. Brain115(Pt 5), 1403–1415 (1992).
   PubMed Web of Science ®Google Scholar
• Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J. Neurol. Neurosurg. Psychiatry74(4), 443–446 (2003).
   PubMed Web of Science ®Google Scholar
• Feuillet L, Reuter F, Audoin B et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult. Scler.13(1), 124–127 (2007).
   PubMed Web of Science ®Google Scholar
• Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol.6(10), 887–902 (2007).
   PubMed Web of Science ®Google Scholar
• MacAllister WS, Belman AL, Milazzo M et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology64(8), 1422–1425 (2005).
   PubMed Web of Science ®Google Scholar
• Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology64(5), 891–894 (2005).
   PubMed Web of Science ®Google Scholar
• Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology70(20), 1891–1897 (2008).
   PubMed Web of Science ®Google Scholar
• Sumowski JF, Wylie GR, Deluca J, Chiaravalloti N. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain133, 362–374 (2010).
   PubMed Web of Science ®Google Scholar
• Arnett PA. Longitudinal consistency of the relationship between depression symptoms and cognitive functioning in multiple sclerosis. CNS Spectr.10, 372–382 (2005).
   PubMed Web of Science ®Google Scholar
• Bobholz, JA, Rao, SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr. Opin. Neurol.16(3), 283–288 (2003).
   PubMed Web of Science ®Google Scholar
• Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J. Clin. Neurosci.14(10), 919–927 (2007).
   PubMed Web of Science ®Google Scholar
• Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch. Clin. Neuropsychol.15(2), 115–136 (2000).
   PubMed Web of Science ®Google Scholar
• Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J. Neurol. Sci.245(1–2), 169–175 (2006).
   PubMed Web of Science ®Google Scholar
• Zipoli V, Goretti B, Hakiki B et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult. Scler.16(1), 62–67 (2010).
   PubMed Web of Science ®Google Scholar
• Flavia M, Stampatori C, Zanotti D, Parrinello G, Capra R. Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis. J. Neurol. Sci.288(1–2), 101–105 (2010).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Filippi M, Minicucci L et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. Am. J. Neuroradiol.21(2), 402–408 (2000).
   PubMed Web of Science ®Google Scholar
• Rao SM, Leo GJ, Haughton VM, Aubin-Faubert PS, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology39(2 Pt 1), 161–166 (1989).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch. Neurol.61(2), 226–230 (2004).
   PubMed Web of Science ®Google Scholar
• Swirsky-Sacchetti T, Mitchell DR, Seward J et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology42(7), 1291–1295 (1992).
   PubMed Web of Science ®Google Scholar
• Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology44(3 Pt 1), 420–425 (1994).
   PubMed Web of Science ®Google Scholar
• Foong J, Rozewicz L, Quaghebeur G et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain120(Pt 1), 15–26 (1997).
   PubMed Web of Science ®Google Scholar
• Sperling RA, Guttmann CR, Hohol MJ et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch. Neurol.58(1), 115–121 (2001).
   PubMed Web of Science ®Google Scholar
• Filippi M, Tortorella C, Rovaris M et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry68(2), 157–161 (2000).
   PubMed Web of Science ®Google Scholar
• Christodoulou C, Krupp LB, Liang Z et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology60(11), 1793–1798 (2003).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Iannucci G, Falautano M et al. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J. Neurol. Sci.195(2), 103–109 (2002).
   PubMed Web of Science ®Google Scholar
• Dineen RA, Vilisaar J, Hlinka J et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain132(Pt 1), 239–249 (2009).
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med.338(5), 278–285 (1998).
   PubMed Web of Science ®Google Scholar
• Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol.50(3), 389–400 (2001).
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology236(1), 254–260 (2005).
   PubMed Web of Science ®Google Scholar
• De Stefano N, Matthews PM, Filippi M et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology60(7), 1157–1162 (2003).
   PubMed Web of Science ®Google Scholar
• Sailer M, Fischl B, Salat D et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain26(Pt 8), 1734–1744 (2003).
   Google Scholar
• Dalton CM, Chard DT, Davies GR et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain127(Pt 5), 1101–1107 (2004).
   PubMed Web of Science ®Google Scholar
• Calabrese M, Atzori M, Bernardi V et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J. Neurol.254(9), 1212–1220 (2007).
   PubMed Web of Science ®Google Scholar
• Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain122(Pt 1), 17–26 (1999).
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain128(Pt 11), 2705–2712 (2005).
   PubMed Web of Science ®Google Scholar
• Pomeroy IM, Matthews PM, Frank JA, Jordan EK, Esiri MM. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain128(Pt 11), 2713–2721 (2005).
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Bo L, Pouwels PJ et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am. J. Neuroradiol.26, 572–577 (2005).
   PubMed Web of Science ®Google Scholar
• Calabrese M, De Stefano N, Atzori M et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol.64(10), 1416–1422 (2007).
   PubMedGoogle Scholar
• Calabrese M, Rocca MA, Atzori M et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology72, 1330–1336 (2009).
   PubMed Web of Science ®Google Scholar
• Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult. Scler.15(8), 933–941 (2009).
   PubMed Web of Science ®Google Scholar
• Calabrese M, Rocca MA, Atzori M et al. A three-years MRI study of cortical lesions in relapse-onset multiple sclerosis. Ann. Neurol.67(3), 376–383 (2010).
   PubMed Web of Science ®Google Scholar
• Calabrese M, De Stefano N, Atzori M et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J. Neurol.255(4), 581–586 (2008).
   PubMed Web of Science ®Google Scholar
• Roosendaal SD, Moraal B, Pouwels PJ et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult. Scler.15(6), 708–714 (2009).
   PubMed Web of Science ®Google Scholar
• Calabrese M, Agosta F, Rinaldi F et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing–remitting multiple sclerosis. Arch. Neurol.66(9), 1144–1150 (2009).
   PubMedGoogle Scholar
• Rao SM, Cognitive Function Study Group, NMSS. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. National Multiple Sclerosis Society, NY, USA (1990).
   Google Scholar
• Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P. Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report. Neurol. Sci. DOI: 10.1007/s10072-010-0346-x (2010) (Epub ahead of print).
   Google Scholar
• Mattioli F, Stampatori C, Bellomi F, Capra R. Natalizumab efficacy on cognitive impairment in MS. Neurol. Sci. DOI: 10.1007/s10072-010-0351-0 (2010) (Epub ahead of print).
   Google Scholar
• Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M. Evidence for progressive gray matter loss in patients with relapsing–remitting MS. Neurology65(7), 1126–1128 (2005).
   PubMed Web of Science ®Google Scholar
• Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology68(9), 634–642 (2007).
   PubMed Web of Science ®Google Scholar
• Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann. Neurol.64(3), 255–265 (2008).
   PubMed Web of Science ®Google Scholar
• Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N. A Wallerian degeneration pattern in patients at high risk for MS. Neurology54(5), 1155–1160 (2000).
   PubMed Web of Science ®Google Scholar
• Chard DT, Griffin CM, McLean MA et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing–remitting multiple sclerosis. Brain125(Pt 10), 2342–2352 (2002).
   PubMed Web of Science ®Google Scholar
• Chard DT, Griffin CM, Rashid W et al. Progressive grey matter atrophy in clinically early relapsing–remitting multiple sclerosis. Mult. Scler.10(4), 387–391 (2004).
   PubMed Web of Science ®Google Scholar
• Charil A, Filippi M. Inflammatory demyelination and neurodegeneration in early multiple sclerosis. J. Neurol Sci.259(1–2), 7–15 (2007).
   PubMed Web of Science ®Google Scholar
• Lanz M, Hahn HK, Hildebrandt H. Brain atrophy and cognitive impairment in multiple sclerosis: a review. J. Neurol.254(Suppl. 2), II43–II48 (2007).
   PubMedGoogle Scholar
• Benedict RH, Carone D, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J. Neuroimaging14(3 Suppl.), S36–S46 (2004).
   PubMed Web of Science ®Google Scholar
• Lazeron RH, de Sonneville LM, Scheltens P, Polman CH, Barkhof F. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult. Scler.12(4), 760–768 (2006).
   PubMed Web of Science ®Google Scholar
• Sanchez MP, Nieto A, Barroso J, Martin V, Hernandez MA. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing–remitting multiple sclerosis. Eur. J. Neurol.15(10), 1091–1099 (2008).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Bruce JM, Dwyer MG et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch. Neurol.63(9), 1301–1306 (2006).
   PubMed Web of Science ®Google Scholar
• Hildebrandt H, Hahn HK, Kraus JA, Schulte-Herbrüggen A, Schwarze B, Schwendemann G. Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult. Scler.12(4), 428–436 (2006).
   PubMed Web of Science ®Google Scholar
• Amato MP, Bartolozzi ML, Zipoli V et al. Neocortical volume decrease in relapsing remitting MS patients with mild cognitive impairment. Neurology63(1), 89–93 (2004).
   PubMed Web of Science ®Google Scholar
• Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. Neuroimage26(4), 1068–1077 (2005).
   PubMed Web of Science ®Google Scholar
• Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology66(5), 685–692 (2006).
   PubMed Web of Science ®Google Scholar
• Portaccio E, Amato MP, Bartolozzi ML et al. Neocortical volume decrease in relapsing–remitting multiple sclerosis with mild cognitive impairment. J. Neurol. Sci.245(1–2), 195–199 (2006).
   PubMed Web of Science ®Google Scholar
• Amato MP, Portaccio E, Goretti B et al. Association of neocortical volume changes with cognitive deterioration in relapsing–remitting multiple sclerosis. Arch. Neurol.64(8), 1157–1161 (2007).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Filippi M, Falautano M et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology50(6), 1601–1618 (1998).
   PubMed Web of Science ®Google Scholar
• Sperling RA, Guttmann CR, Hohol MJ et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch. Neurol.58(1), 115–121 (2001).
   PubMed Web of Science ®Google Scholar
• Locatelli L, Zivadinov R, Grop A, Zorzon M. Frontal parenchymal atrophy measures in multiple sclerosis. Mult. Scler.10(5), 562–568 (2004).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Zivadinov R, Carone D et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. Am. J. Neuroradiol.26(7), 1824–1831 (2005).
   PubMed Web of Science ®Google Scholar
• Tekok-Kilic A, Benedict RH, Weinstock-Guttman B et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage36(4), 1294–1300 (2007).
   PubMed Web of Science ®Google Scholar
• Morgen K, Sammer G, Courtney SM et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS. Neuroimage30(3), 891–898 (2006).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J. Neurol. Neurosurg. Psychiatry80(2), 201–206 (2009)
   PubMed Web of Science ®Google Scholar
• Deichmann R, Good CD, Josephs O, Ashburner J, Turner R. Optimization of 3-D MP-RAGE sequences for structural brain imaging. Neuroimage12(1), 112–127 (2000).
   PubMed Web of Science ®Google Scholar
• Deichmann R, Schwarzbauer C, Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. Neuroimage21(2), 757–767 (2004).
   PubMed Web of Science ®Google Scholar
• Zeng X, Staib LH, Schultz RT, Duncan JS. Segmentation and measurement of the cortex from 3-D MR images using coupled-surfaces propagation. IEEE Trans. Med. Imaging18(10), 927–937 (1999).
   PubMed Web of Science ®Google Scholar
• Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl Acad. Sci. USA97(20), 11050–11055 (2000).
   PubMed Web of Science ®Google Scholar
• Jones SE, Buchbinder BR, Aharon I. Three-dimensional mapping of cortical thickness using Laplace’s equation. Hum. Brain Mapp.11(1), 12–32 (2000).
   PubMed Web of Science ®Google Scholar
• MacDonald D, Kabani N, Avis D, Evans AC. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage12(3), 340–356 (2000).
   PubMed Web of Science ®Google Scholar
• Miller MI, Massie AB, Ratnanather JT, Botteron KN, Csernansky JG. Bayesian construction of geometrically based cortical thickness metrics. Neuroimage12(6), 676–687 (2000).
   PubMed Web of Science ®Google Scholar
• Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage9(2), 179–194 (1999).
   PubMed Web of Science ®Google Scholar
• Fischl B, Sereno M, Dale AM. Cortical surface-based analysis. II. Inflation, flattening and a surfacebased coordinate system. Neuroimage9(2), 272–284 (1999).
   Google Scholar
• Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage23(3), 1168–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Calabrese M, Rinaldi F, Mattisi I et al. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology74(4), 321–328 (2010).
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA. Cortical reorganisation in patients with MS. J. Neurol. Neurosurg. Psychiatry75(8), 1087–1089 (2004)
   PubMed Web of Science ®Google Scholar
• Rocca MA, Colombo B, Falini A. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol.4(10), 618–626 (2005).
   PubMed Web of Science ®Google Scholar
• Calabrese P, Penner IK. Cognitive dysfunctions in multiple sclerosis: a multiple disconnection syndrome’? J. Neurol.254(Suppl. 2), II18–II21 (2007). Erratum in: J. Neurol.255, 309–310 (2008).
   PubMed Web of Science ®Google Scholar